Nov 17, 2020 / 08:00PM GMT
Jacob K. Johnson - Stephens Inc., Research Division - Analyst
All right. Good afternoon, everybody. I'm Jacob Johnson, the life science tools and diagnostics analyst here at Stephens. Welcome to day 2 of the Stephens Conference. Happy to be joined by the Bio-Techne team this afternoon. We got CEO, Chuck Kummeth; CFO, Jim Hippel; along with Dave Clair, Senior Director of IR and Corporate Development.
(Operator Instructions)
With that out of the way, Chuck, maybe to kick things off, if you just want to give a brief overview of the Bio-Techne story, and then we'll jump into Q&A.
Charles R. Kummeth - Bio-Techne Corporation - CEO, President & Director
Sure. Well, I just had my 30th earnings call, so it's been 7.5 years. Jim is here on the call with me, he's close behind me at -- going on 7 years. Dave just joined a year ago, but he's been working with us for at least 3, if not 4. And been a big help, by the way.
We are a reagents, tools -- reagents and tools company for life sciences industry. We have a lot of products. We're very
Bio-Techne Corp at Stephens NASH Investment Conference (Virtual) Transcript
Nov 18, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers